To determine the contribution of QseA, change in ler expression was monitored in qseA deletion MRT67307 manufacturer (VS145) and complemented (VS151) strains. Isolimonic acid (100 μg/ml) treated
cultures demonstrated a <2 fold change in ler expression in qseA deletion mutant. In comparison, isolimonic acid repressed the ler by 7.4 fold in complemented strain VS151 (Figure 7A). To further confirm the role of QseA, qseA was overexpressed by introducing the plasmid pVS150, harboring qseA, into reporter strain TEVS232 and expression of chromosomal fusion LEE1:LacZ (β-galactosidase activity) was measured. Overexpression of qseA from a multicopy plasmid negated the inhibitory activity of isolimonic acid (Figure 7B). Furthermore, the possibility of transcriptional see more regulation of qseA by isolimonic acid was determined by assessing the qseA expression. A < 2 fold change in the transcript levels of qseA indicated that isolimonic acid do not regulate the expression of qseA (Figure 7C). Altogether, the isolimonic acid appears to repress ler expression and possibly LEE by modulating QseA activity. Figure 7 Isolimonic acid requires QseA to repress ler. (A) Expression of ler in ΔqseA mutant and ΔqseA
mutant supplemented with p qseA. The expression was monitored 30 min after addition of preconditioned media and 100 μg/ml isolimonic acid. (B) AI-3 induced β-galactosidase activity in TEVS232 supplemented with qseA (AV46). Asterisk denotes significant (p<0.05) difference from solvent control (DMSO). (C) Expression of qseA in presence of 100 μg/ml isolimonic acid. Fold change values were calculated over EHEC grown in presence of DMSO. The data represents mean ±SD of triplicate experiment. Discussion EHEC
is an important gastrointestinal Phenylethanolamine N-methyltransferase pathogen, prolific biofilm former and demonstrates resistance to various antimicrobials in biofilm mode of growth [51]. For successful colonization of gastrointestinal tract and initiation of infection, adhesion of EHEC to intestinal epithelium is an essential early event [47, 48]. Additionally, several E. coli pathovars were reported to produce and live in biofilms inside the human body [19]. In order to counteract these maladies, an antivirulence molecule with anti-adhesion and/or anti-biofilm properties may be highly desirable. Research in our laboratory has identified several selleck products molecules with differing anti-virulence effects [23, 28, 36, 37, 52, 53]. The current work examined the potential of five citrus limonoids- isolimonic acid, ichangin, isoobacunoic acid, IOAG and DNAG, to inhibit EHEC biofilm and TTSS. All the tested limonoids seem to interfere with the EHEC biofilm formation in a dose dependent fashion (Figure 2). Isolimonic acid was the most potent inhibitor of the EHEC biofilm and adhesion to Caco-2 cells.